I presume this is what's going to be presented on the weekend:
"The trial, which took place entirely at Ohio State, involved 49 patients with metastatic or recurrent tumors and a median of four prior lines of chemotherapy who received at least one inoculation of B-Vaxx. Of these, 28 patients received three or more vaccinations. Two of these patients showed a partial response and 14 exhibited stable disease."
http://cancer.convio.net/site/PageServer?pagename=OncUpdate_March_2019_AnticancerVaccineStudy
Ohio State University B-Vaxx Report
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
-0.001(2.50%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 4.0¢ | 4.0¢ | 3.8¢ | $467.7K | 11.95M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 1555851 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 252389 | 4 |
View Market Depth
| Last trade - 16.10pm 28/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
